The controversy over embryonic stem cell research will not dissipate until the technology proves itself in the clinic. Now the regulators have to move, say Science|Business’s Nuala Moran.
Ireland’s largest-ever healthcare venture capital fund is making its optimistic debut as one of the UK’s longest-standing VC supporters of high tech start-ups calls it quits. So what’s happening?
Basic science remains of central importance, John Denham, UK Secretary of State for Innovation reassured the UK’s leading scientists in a speech last month.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.